Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine
... Ogru, Executive Vice President of Research and Development at Phosphagenics said; "While we have previously demonstrated the penetrative power of our tpm
technology, the success of this trial validates the versatility and precision of Phosphagenics' drug delivery platform in humans. We view this as a m...
Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
... - Company's tpm
Drug Delivery Technology Demonstrates Substantial ...e study was designed to demonstrate the ability of tpm
lidocaine (5%) to a targeted local site...in both skin and muscle.
These results show that tpm
has the potential to be used as a targeted,
Phosphagenics to Commence Phase 2 TPM/Insulin Clinical Trial
...ine, fentanyl, oxycodone, atropine,
estradiol, testosterone) to large molecules (e.g. insulin and PTH) -- from
a single application. Additionally, the tpm
delivery technology can be
cost-effectively manufactured in a wide range of presentations (e.g. gel,
paste, liquid and powder) adding value to existin...
Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
...The positive results of the trial demonstrated the ability of the
technology to deliver insulin into the bloodstream in a
non-invasive manner...cules (e.g. insulin and PTH) - from a
single application. Additionally, the tpm
delivery technology can be cost-
effectively manufactured in a wide range o...
TPM in Biological News
BIO-key(R) Granted Additional Patent for Biometric Security Solution
...2006, many new
laptop computers have been sold with an embedded Trusted Platform Module
chip. The primary attributes of this patent focus on using the tpm
encrypt the biometric image or template before it is transmitted, thereby
providing protection from attempts to hack into the computer or the
Atmel's FingerChip Biometric Sensor Selected by Rise Computer for its Robust Security
...itors at Computex 2008 in Taipei. Please
come to see Atmel's FingerChip and tpm
solutions at Booth N027 and Rise's
LCD PC at Booth L329a, L330, L331a and L...y be
trademarks of others.
For more information on Atmel's tpm
products, go to
For more informa...
TPM in Biological Technology
Phosphagenics Announces Completion of Transdermal Patch Prototypes
...systems is a major step in advancing the Company's tpm
delivery platform technology," said Dr. Esra Ogru,...ped both reservoir and matrix patches that contain tpm
and oxycodone and produce sustained delivery. A re... course of the trial.
"The development of our tpm
patch has the potential to be a substantial commer...
Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results
...trial in 16 healthy
subjects. The trial endpoints were to evaluate the safety and tolerability
of the TPM/Oxycodone formulation and the ability of the tpm
deliver oxycodone into the body.
The oxycodone, administered as a single transdermal application, was
safe with no adverse events repo...